SCHEMBL1072803

SCHEMBL1072803

O=S(=O)(O)c1ccnc(-c2cc(S(=O)(=O)O)ccn2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HSD17B10 Q99714 4/20 0.43
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
NAPRT Q6XQN6 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 5/20 0.42
KDM6B O15054 2/20 0.41
KDM5C P41229 2/20 0.41
KDM4C Q9H3R0 2/20 0.41
KDM2A Q9Y2K7 2/20 0.41
KDM3A Q9Y4C1 2/20 0.41
KDM4A O75164 1/20 0.41
LMNA P02545 2/20 0.41
CCR1 P32246 2/20 0.41
CCR5 P51681 2/20 0.41
CCR8 P51685 2/20 0.41
P4HA1 P13674 1/20 0.40
NT5E P21589 1/20 0.39
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29774730 1.00 ALDH1A1 (0.43) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL12313526 0.90 KDM4E (0.56) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL16361065 0.88 CCR1 (0.63) ALDH1A1TDP1SMN1; SMN2KDM4ELMNA
SCHEMBL8847160 0.86 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL13651788 0.80 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL27673210 0.80 KDM4E (0.52) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL3466579 0.80 UHRF1 (0.46) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL28157668 0.80 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRTDP1NAPRT
Hydrochloric Acid SCHEMBL28177603 0.79 RECQL (0.42) ALDH1A1HSD17B10TSHRTDP1NAPRT
SCHEMBL12837712 0.78 KDM4E (0.44) ALDH1A1HSD17B10SMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12261336-B2 Microbial fuel cell using electron absorber having high reduction potential, and method of generating electric energy using same PARK, Yong Hak (KR) 2025-03-25 US claimed
US-20240234778-A9 MICROBIAL FUEL CELL USING ELECTRON ABSORBER HAVING HIGH REDUCTION POTENTIAL, AND METHOD OF GENERATING ELECTRIC ENERGY USING SAME PARK YONG HAK (KR) 2024-07-11 US claimed
US-20240136560-A1 MICROBIAL FUEL CELL USING ELECTRON ABSORBER HAVING HIGH REDUCTION POTENTIAL, AND METHOD OF GENERATING ELECTRIC ENERGY USING SAME PARK, YONG HAK (KR) 2024-04-25 US claimed
EP-4047699-A1 MICROBIAL FUEL CELL USING ELECTRON ABSORBER HAVING HIGH REDUCTION POTENTIAL, AND METHOD OF GENERATING ELECTRIC ENERGY USING SAME Park, Yong Hak (KR) 2022-08-24 EP claimed
US-8986436-B2 Luminescent pigments and their use in security applications Fábrica Nacional de Moneda y Timbre—Real Casa de la Moneda (ES) 2015-03-24 US claimed
EP-2673335-B1 LUMINESCENT PIGMENTS AND THEIR USE IN SECURITY APPLICATIONS FÁBRICA NAC DE MONEDA Y TIMBRE REAL CASA DE LA MONEDA (ES) 2014-12-10 EP claimed
US-20140158019-A1 LUMINESCENT PIGMENTS AND THEIR USE IN SECURITY APPLICATIONS FABRICA NAIONAL DE MONEDA Y TIMBRE- REAL CASA DE LA MONEDA (ES) 2014-06-12 US claimed
EP-2673335-A1 LUMINESCENT PIGMENTS AND THEIR USE IN SECURITY APPLICATIONS Fábrica Nacional de Moneda Y Timbre - Real Casa de la Moneda (ES) 2013-12-18 EP claimed
WO-2012107558-A1 LUMINESCENT PIGMENTS AND THEIR USE IN SECURITY APPLICATIONS FÁBRICA NACIONAL DE MONEDA Y TIMBRE - REAL CASA DE LA MONEDA (ES) 2012-08-16 WO claimed
US-20110083732-A1 Novel ruthenium complex and photoelectric component using the same EVERLIGHT USA, INC. (US) 2011-04-14 US claimed
US-20100096005-A1 Ruthenium complex and photoelectric component using the same EVERLIGHT USA, INC. (US) 2010-04-22 US claimed
US-20100084018-A1 Ruthenium complex and photoelectric component using the same EVERLIGHT USA, INC. (US) 2010-04-08 US claimed
US-12261336-B2 Microbial fuel cell using electron absorber having high reduction potential, and method of generating electric energy using same PARK, Yong Hak (KR) 2025-03-25 US disclosed
US-20240234778-A9 MICROBIAL FUEL CELL USING ELECTRON ABSORBER HAVING HIGH REDUCTION POTENTIAL, AND METHOD OF GENERATING ELECTRIC ENERGY USING SAME PARK YONG HAK (KR) 2024-07-11 US disclosed
US-20240136560-A1 MICROBIAL FUEL CELL USING ELECTRON ABSORBER HAVING HIGH REDUCTION POTENTIAL, AND METHOD OF GENERATING ELECTRIC ENERGY USING SAME PARK, YONG HAK (KR) 2024-04-25 US disclosed
EP-4047699-A1 MICROBIAL FUEL CELL USING ELECTRON ABSORBER HAVING HIGH REDUCTION POTENTIAL, AND METHOD OF GENERATING ELECTRIC ENERGY USING SAME Park, Yong Hak (KR) 2022-08-24 EP disclosed
US-5968745-A ELECTRODE OF SUBSTRATE HAVING ELECTROCONDUCTIVE WORKING SURFACE AND A NONCONDUCTIVE OUTER POLYMER LAYER WHERE PROBES CAN BE ATTACHED HAVING MICROFLUIDIC REACTION OPENINGS FOR TRANSITION METAL COMPLEX TO TRANSFER ELECTRONS TO SURFACE THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1999-10-19 US disclosed
US-5871918-A DNA AND RNA HYBRIDIZATION DETECTION BY REACTION WITH TRANSITION METAL COMPLEX FOR OXIDATION-REDUCTION REACTION THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1999-02-16 US disclosed
EP-0871773-A2 ELECTROCHEMICAL DETECTION OF NUCLEIC ACID HYBRIDIZATION UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1998-10-21 EP disclosed
WO-1997001646-A2 ELECTROCHEMICAL DETECTION OF NUCLEIC ACID HYBRIDIZATION THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1997-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100084018-A1 Ruthenium complex and photoelectric component using the same CRY2, RFC2, AP2M1 ALDH1A1 1091/4885HSD17B10 3496/4885TSHR 4351/4885
US-20110083732-A1 Novel ruthenium complex and photoelectric component using the same L1CAM, CRY2, RUVBL2 ALDH1A1 1536/4885HSD17B10 3539/4885TSHR 3809/4885
US-20100096005-A1 Ruthenium complex and photoelectric component using the same CRY2, CRY1, AP2M1 ALDH1A1 743/4885HSD17B10 3245/4885TSHR 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.